{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:30:16Z","timestamp":1791390616266,"version":"4.3.3"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.neuropharm.2013.06.014","type":"journal-article","created":{"date-parts":[[2013,6,22]],"date-time":"2013-06-22T10:03:37Z","timestamp":1371895417000},"page":"380-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Protection of dopaminergic neurons by 5-lipoxygenase inhibitor"],"prefix":"10.1016","volume":"73","author":[{"given":"Kai-Hsiang","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Hui","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mann-Jen","family":"Hour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houng-Chi","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Mei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.06.014_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1432-1033.1993.tb18012.x","article-title":"5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase","volume":"215","author":"Abramovitz","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib2","doi-asserted-by":"crossref","first-page":"23679","DOI":"10.1074\/jbc.274.34.23679","article-title":"Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate","volume":"274","author":"Brash","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuroscience.2012.10.009","article-title":"Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability","volume":"228","author":"Chou","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.23642","article-title":"5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease","volume":"72","author":"Chu","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-9-127","article-title":"Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer's disease mouse model","volume":"9","author":"Chu","year":"2012","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib6","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.neurobiolaging.2012.12.009","article-title":"5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in\u00a0vivo: involvement of the cyclin-dependent kinase-5","volume":"34","author":"Chu","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib7","doi-asserted-by":"crossref","first-page":"28163","DOI":"10.1074\/jbc.273.43.28163","article-title":"A\u00a0relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells","volume":"273","author":"Datta","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/384039a0","article-title":"The PPARalpha-leukotriene B4 pathway to inflammation control","volume":"384","author":"Devchand","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib10","first-page":"1","article-title":"Leukotriene B4 in inflammation","volume":"10","author":"Ford-Hutchinson","year":"1990","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.bi.63.070194.002123","article-title":"5-Lipoxygenase","volume":"63","author":"Ford-Hutchinson","year":"1994","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib12","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib13","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1523\/JNEUROSCI.23-15-06181.2003","article-title":"Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons","volume":"23","author":"Gao","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1471-4159.2006.03828.x","article-title":"Activation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neurons","volume":"97","author":"Ge","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib15","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1523\/JNEUROSCI.4144-09.2009","article-title":"Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease","volume":"29","author":"Ghosh","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib16","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1124\/mol.108.048611","article-title":"Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity","volume":"74","author":"Hung","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-3-12","article-title":"Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia","volume":"3","author":"Jatana","year":"2006","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib18","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0197-4580(02)00021-0","article-title":"Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity","volume":"23","author":"Klegeris","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","article-title":"Role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone","volume":"164","author":"Kumar","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1471-4159.1996.66010147.x","article-title":"Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling","volume":"66","author":"Lammers","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2008.08.053","article-title":"Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity","volume":"445","author":"Li","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib23","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1073\/pnas.81.19.6212","article-title":"Leukotrienes in the rat central nervous system","volume":"81","author":"Lindgren","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2013.06.014_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bj3330045","article-title":"Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of the arachidonate cascade","volume":"333","author":"Maccarrone","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pnpbp.2010.07.032","article-title":"Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease","volume":"35","author":"Manev","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2001.tb03610.x","article-title":"Neurogenesis and neuroprotection in the adult brain. A putative role for 5-lipoxygenase?","volume":"939","author":"Manev","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib27","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1471-4159.1999.0730112.x","article-title":"Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures","volume":"73","author":"Mytilineou","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresrev.2006.02.002","article-title":"Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders","volume":"52","author":"Phillis","year":"2006","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib30","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ejmech.2007.09.007","article-title":"Investigations concerning the COX\/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles","volume":"43","author":"Scholz","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI200318338","article-title":"The organization and consequences of eicosanoid signaling","volume":"111","author":"Soberman","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib32","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1523\/JNEUROSCI.5529-08.2009","article-title":"Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke","volume":"29","author":"Sobrado","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib33","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1073\/pnas.93.11.5241","article-title":"Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis","volume":"93","author":"Tang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2013.06.014_bib34","first-page":"220","article-title":"The role of eicosanoids in the brain","volume":"17","author":"Tassoni","year":"2008","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s10753-010-9191-6","article-title":"Zileuton reduces inflammatory reaction and brain damage following permanent cerebral ischemia in rats","volume":"33","author":"Tu","year":"2010","journal-title":"Inflammation"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-398314-5.00004-0","article-title":"Inflammation in Parkinson's disease","volume":"88","author":"Tufekci","year":"2012","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib37","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1096\/fj.00-0836fje","article-title":"Glucocorticoid receptors are required for up-regulation of neuronal 5-lipoxygenase (5LOX) expression by dexamethasone","volume":"15","author":"Uz","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0929-7855(95)00018-L","article-title":"5-Lipoxygenase-activating protein (FLAP)","volume":"12","author":"Vickers","year":"1995","journal-title":"J.\u00a0Lipid Mediat. Cell Signal."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1024789810277","article-title":"Roles of 5-lipoxygenase activating protein in cell proliferation and apoptosis","volume":"19","author":"Wu","year":"2003","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib40","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib41","first-page":"1086","article-title":"SH-SY5Y human neuroblastoma cell line: in\u00a0vitro cell model of dopaminergic neurons in Parkinson's disease","volume":"123","author":"Xie","year":"2010","journal-title":"Chin Med. J. (Engl)"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4615-4861-4_4","article-title":"Arachidonate 12-lipoxygenase isozymes","volume":"447","author":"Yamamoto","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib43","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/42506","article-title":"A\u00a0G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis","volume":"387","author":"Yokomizo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neulet.2005.07.008","article-title":"Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia","volume":"387","author":"Yu","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.06.014_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1440-1789.2006.00658.x","article-title":"Expression patterns of 5-lipoxygenase in human brain with traumatic injury and astrocytoma","volume":"26","author":"Zhang","year":"2006","journal-title":"Neuropathology"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib46","first-page":"150","article-title":"5-lipoxygenase is involved in rotenone-induced injury in PC12 cells","volume":"40","author":"Zhang","year":"2011","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.neuropharm.2013.06.014_bib47","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1745-7254.2006.00406.x","article-title":"Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats","volume":"27","author":"Zhou","year":"2006","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:13:54Z","timestamp":1588958034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813002827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":47,"alternative-id":["S0028390813002827"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.014","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection of dopaminergic neurons by 5-lipoxygenase inhibitor","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}